Trump’s New Promise To Americans
President Donald Trump is doubling down on a powerful election message for 2026: affordability, especially when it comes to prescription drugs. And new data suggests his policies are delivering results Americans haven’t seen in decades.
In a weekend post on Truth Social, President Trump highlighted the historic price cuts now taking effect because of his Favored Nations executive action — a policy that forces drug companies to give Americans the same low prices they offer overseas.
“Drug prices are falling at levels never seen before — 500%, 600%, 700%, and more,” Trump wrote. “Republicans must remind voters that this was done by us, and nobody else.”
Trump called the drop in drug prices “a revolution in medicine” and urged GOP candidates to proudly campaign on affordability, seniors’ healthcare, and protecting Americans from Big Pharma.
Major Drug Companies Forced to Slash Prices Under Trump
In recent months, Trump’s aggressive approach has pushed several major drug manufacturers into landmark agreements:
✔ Novo Nordisk and Eli Lilly
Agreed to steep discounts on GLP-1 weight-loss drugs, allowing more Americans — especially seniors — to access breakthrough treatments.
✔ AstraZeneca
Promised to match the lowest drug prices they charge anywhere in the world for Medicaid patients. Many of their key medicines will now be featured on the official TrumpRx.com savings portal.
✔ Pfizer
Became the first major pharmaceutical company to comply with Trump’s “most favored nation” policy earlier this fall.
These price drops represent one of the most significant shifts in the U.S. drug market in modern history — a direct result of Trump’s pressure campaign and willingness to take on Big Pharma when others wouldn’t.
New Survey: Americans Overwhelmingly Support Trump’s Health Agenda
A nationwide survey commissioned by the Pharmaceutical Reform Alliance shows the public strongly supports Trump’s affordability push:
- 86% support Trump’s drug-price reforms
- 85% believe prescription costs have become too high
- Voters blame pharmaceutical companies for skyrocketing costs
- Candidates who support Trump’s Favored Nations policy enjoy a strong advantage heading into 2026
For seniors, retirees, and Americans living on fixed incomes, Trump’s affordability message is resonating in a major way.
Democrats Try to Spin Rising Costs — Trump Fires Back
Democrats have attempted to use inflation and cost-of-living concerns to attack Republicans ahead of the 2026 midterms. But Trump has repeatedly called the narrative misleading, pointing to real-world data showing dramatic price reductions during his second term.
He recently cited Thanksgiving prices as an example:
“Walmart said Thanksgiving dinner was 25% more expensive under Biden,” Trump noted. “That’s a big number — and Walmart is respected.”
Trump says Democrats are pushing a “con job” to distract from their own failed economic record.
Why This Message Matters for 2026
Affordability — especially for seniors — is one of the highest-value topics in online search and one of the most monetizable in digital news. Trump’s strategy ties together:
- Lower drug prices
- Stronger Medicare savings
- Fixed-income protection for retirees
- Relief from inflation
- Senior-focused healthcare reform
For Republicans running in 2026, Trump believes this message is a political powerhouse.
“We should win the Midterm Elections in RECORD NUMBERS,” the president said. “I am the Affordability President.”
Bottom Line
Trump’s affordability agenda — especially the unprecedented drop in prescription drug prices — gives Republicans a powerful, high-impact message heading into 2026. With broad public support and landmark deals already in place, the president is urging the GOP to run on results, not rhetoric.
